canadian pharmacy
Coordinating European Future Internet Research

FIT-IT Programme

_____________________________________________________________________

SUMMARY

FIT-IT is an canadian pharmacy programme that focuses on high-quality research in the area of information and communication technology. Currently, there are five programme lines: “embedded systems”, “semantic systems and services”, “systems-on-chip”, “trust in IT-systems” and “visual computing”. The programme receives over €15 million funding from the Austrian government every year.

_____________________________________________________________________

SOLUTIONS

 

  • Embedded systems:
    • Developing Rapid prototyping (with “hardware in the loop”) and formal verification and design validation processes
    • Integrating input-output streams for sensor-actuator technologies
    • Creating capacities for interoperability and dynamic reconfiguration within systems
    • Managing scarce resources
  • Semantic systems:
    • Simplifying conditions for human-computer interaction
    • Designing a a simplified co-complex web-based service which connects syntactically and semantically similar elements in different information systems to allow for superior data content
  • Systems on chip:
    • Investigating Sub-micron Technology and mixed analog and digital systems
    • Managing the complexity in design and design methodology
    • Assuring quality from design to system
  • Trust in IT:
    • Designing secure network protocols and operating systems from the ground up, improving on current ad-hoc security systems
    • Developing new cryptology methods
    • Creating technologies for privacy and identity management, especially in the area of mobile communication applications

_____________________________________________________________________

LINK: http://www.fit-it.at/english/index.html

_____________________________________________________________________

Back to Austria

This entry was posted in Uncategorized and tagged , , , . Bookmark the permalink.

Comments are closed.